These results clarify the molecular mechanism by which the KLK1‐B1R axis inhibits inflammation‐cancer transformation by regulating fibroblast phenotypic transformation and ECM dynamic balance, providing a new strategy for targeted intervention. This evidence concerns the gene BDKRB1 and cancer.